Cancer immunotherapy: anti-PD-1 & anti-CTLA-4 antibodies

Anti-CTLA-4
mAb.

Tumor inhibits T-cell & evades immune T cell stays activated & destroys
destruction. the tumor cell.

CTLA-4 = cytotoxic T-lymphocyte-associated protein 4; mAb = monoclonal antibody;
PD-1 = programmed death receptor-1; PD-L1 = programmed death ligand-1.
Â©uWorid
